Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients

Author： Mourad J. J.   Le Jeune S.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.9, 2009-09, pp. : 2271-2280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial

By Farsang Csaba  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 333-344

Springer Publishing Company

Access to resources Recommend Favorite

Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study

By Barrios Vivencio   Escobar Carlos   Divison Juan Antonio   Medialdea Francisco  

Therapy, Vol. 4, Iss. 5, 2007-09 ,pp. : 677-683

Future Medicine

Access to resources Recommend Favorite

Association between Altered Circadian Blood Pressure Profile and Cardiac End-Organ Damage in Patients with Renovascular Hypertension

By  

Cardiology, Vol. 100, Iss. 3, 2003-11 ,pp. : 114-119

Karger

Access to resources Recommend Favorite

Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study

By Holzgreve Heinrich   Risler Teut   Trenkwalder Peter  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1849-1858

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy

By  

Cardiology, Vol. 134, Iss. 1, 2016-01 ,pp. : 1-10

Karger

Access to resources Recommend Favorite